ʻAʻoleʻike ka poʻe i ka maʻi o ka diabetes type 2 i ka pae o ka glucose koko maʻamau ma o kaʻai a me ka hoʻoikaika. No laila, pono e hoʻohana kekahi o nā maʻi maʻi maʻi hypoglycemic a me Glidiab.
Ke kōkua nei kēia lāʻau lapaʻau e hoʻopaʻa i ka pae o ka glucose i ke koko, a hoʻonui i ka hiki i ka hoʻoikaika ʻia o ka lāʻau ʻaina inā i loaʻa ka maʻi lolo i ka momona. Eia kekahi, ke hoʻohana nei iā Glidiab MV 30, ua hoʻihoʻi ʻia ka papa o ka huna ʻana i ka insulin.
Pehea e hiki ai iaʻu ke kūʻai aku i ka lāʻau lapaʻau Glidiab? I loko o kahi lāʻauʻai, ke kumukūʻai o ka lāʻau lapaʻau he 120-200 mau rubles. Aia ke kumukūʻai e hilinaʻi i ka nui o nā mea hana i loko o ka papaʻaina. ʻO Glidiab MB 30 mg a me 80 mg kahi i hoʻolako ʻia.
ʻO ka hana o ka hana a me nā hōʻike no ka hoʻohana
ʻO Glidiab MV kahi kikowaena hypoglycemic pili i ka pūʻulu o nā derogatives sulfonylurea o ka hanauna 2. ʻO ka lāʻau lapaʻau ka hopena o ka gliclazide a me nā mea hanu. ʻO Glyclazide i loko o kahi papa he 80 mg a 30 mg paha.
Pehea ka hana lima o ka lāʻau lapaʻau? Hoʻoulu ʻo Glyclazide i ka lawe ʻana i ka hana glycogen synthetase a me ka hoʻonaʻauao ʻana i ka insulin. Eia kekahi, hoʻoneʻe ʻia kēia waiwai i ka hopena huna o ka glucose i ka glucose, a loaʻa i ka hoʻonui ʻana i ke ʻano o ka ʻolima peripheral i insulin.
Eia kekahi, kōkua ke gliclazide e hōʻemi i ka ʻoka ma waena o ka ʻai ʻana o ka meaʻai a me ka hoʻomaka ʻana o ka huna ʻana ikaika o ka insulin. Inā ʻoe e nānā i nā ʻōlelo aʻoaʻo no ka hoʻohana ʻana no Glidiab, hiki iā ʻoe ke ʻike, i ka wā e hoʻohana ai ʻoe i nā papa, a laila e iho ana ke kiʻekiʻe o ka hyperglycemia, a ua hoʻihoʻi ʻia ke kakahiaka o ka huna ʻana o ka insulin.
Aia kēia mau mea āpau e pili kūpono i ka minamina o ka paʻakai a me ka microcirculation. Inā ʻoe e manaʻoʻiʻo i nā ʻōkuhi, a laila kōkua ka Glidiab MV i ka hoʻohaʻahaʻa ʻana i ka adhesion a me ka hōʻuluʻulu ʻana o nā platelets, a ma ka manawa like e hoʻomaʻamaʻa i nā vascular permeability. E maʻalahi, me ka hoʻohana ʻana i nā papa, ʻo ka hopena o ka holomua o ka microthrombosis a me ka atherosclerosis ua hoʻemi nui ʻia.
Ua loaʻa nā noiʻi pū kekahi e kōkua ana kahi hypoglycemic hoʻolalelale i ka hoʻomohala ʻana o nā hoʻopiʻi e like me ka retinopathy diabetic ma kahi hana mua-proliferative. Eia kekahi, ʻo ka hoʻohana ʻana i nā papa Glidiab MV hiki ke hoʻonui nui i ka maikaʻi o ka mālama ʻana i ka lāʻau lapaʻau i nā mea maʻi e hōʻeha nei i ka momona.
Makemake wau e nānā i nā metabolites o ka lāʻau lapaʻau e hoʻopili pū me ka urine i kahi ʻano ʻole, a hui pū ʻia me nā feces ma ke ʻano o nā metabolites.
Nā ʻōkuhi no ka hoʻohana ʻana i ka lāʻau lapaʻau
I nā hihia he aha ke kūpono e hoʻohana ʻia i nā papa Glidiab 80? Ke ʻōlelo nei nā ʻōlelo aʻoaʻo he pono e hoʻohana i ka lāʻau lapaʻau i ka mālama ʻana i ka maʻi mellitus no ke ʻano type 2, inā ʻaʻole kōkua ke ʻano o ka mālama ʻana a me ka hana kino kūlohelohe i nā pae glucose.
I ka launa pū ʻana me nā lāʻau lapaʻau ʻē aʻe, ʻo Glidiab MB ka mea nui loa i hoʻohana ʻole ʻia. Akā e hōʻike ʻia e hiki ke hoʻonui ʻia ka hopena hypoglycemic o ka lāʻau inā he, me ka lāʻau lapaʻau lāʻau, ʻai ʻia a me ke pāʻani ʻana i ka haʻuki.
Pehea e lawe ai i nā lāʻau lapaʻau? ʻO ka ʻōlelo mua ma kahi 80 mg. Eia nō naʻe, ʻo 2 ka manawa o ka hoʻohana i nā lā - i ke kakahiaka a i ke ahiahi. A manaʻo ʻia e lawe i nā papa 30-60 mau minuke ma mua o ka ʻai ʻana.
Inā loaʻa ʻole ka hopena liʻiliʻi loa o ka 80 mg i ka hopena hypoglycemic, a laila mahuahua ka dosage. ʻO ka maʻamau, no ka maʻi maʻamau o ka maʻi lā 2, ʻo kahi momona o 160 mg ka mea kiʻekiʻe. ʻO ka dosage kiʻekiʻe loa o ka lāʻau lapaʻau he 320 mg.
Akā e hoʻomanaʻo hoʻi mākou me ka nui o nā hewa, e hoʻonui nui ʻia ka ulu ʻana o ka hypoglycemia a me nā hoʻopiʻi ʻē aʻe.
Nā lāʻau lapaʻau a me nā contraindications
Pono e hoʻomanaʻo ʻia o kekahi mau lāʻau lapaʻau ke hoʻonui i ka hopena hypoglycemic o ka lāʻau Glidiab MB. No laila, ke kuhikuhi nei nā ʻōkuhi e pono e hui pū me ka lāʻau lapaʻau me ka blockamine hist2 H2-receptor, non-steroidal anti-inflammatory drug, antifungal agents, ACE inhibitors.
Nā lāʻau anti-tuberkulosis, nā beta-adrenoblockers, nā indicoagulant type type antimonagulants, anabolic steroid, MAO inhibitors, salicylates a me nā mea ʻē aʻe kekahi e hiki ke hoʻonui i nā hopena hypoglycemic.
ʻO ia ke kumu ma mua o ka hoʻohana ʻana i nā papa Glidiab, pono ʻoe e ʻike pono i nā ʻōkuhi a nīnau aku i kahi kauka.
I waena o nā contraindications i ka hoʻohana ʻana i nā papa i hiki ke hoʻomaopopo ʻia:
- ʻO ka maʻi diabetes type 1 ka hilinaʻi ʻana i nā insulin.
- Maʻi molaʻi.
- ʻO nā precomatous a i ʻole coma. Eia kekahi, ʻo kahi contraindication koʻikoʻi he hyperosmolar coma.
- Leukopenia
- ʻO ka wā hāpai.
- ʻO ka manawa lactation.
- ʻO ka maʻi hepatic a me ka maikaʻi ʻole ʻole.
- Nā kūlana i hui pū ʻia e ka pale hewa ʻana o ke kaʻina o ka paʻa ʻana o ka meaʻai, a me ka hoʻomohala ʻana o ka hypoglycemia. ʻO kēlā mau ʻano ka komo ʻana o ka ʻōpū, ka paresis o ka ʻōpū a me nā maʻi maʻi.
- Hoʻopili i nā mea o nā papa.
- ʻO nā kūlana e noi ʻia ai ka insulin insulin. Ke ʻano nei i kēia mau hiʻohiʻona, nā hōʻeha, a me nā hana hōʻeuʻeu.
- Alikaihue
- ʻO nā maʻi pīpī.
Eia kekahi, pono ka lāʻau e hoʻohana me ka akahele i ka poʻe e hōʻeha nei i ka maʻi thyroid.
ʻO nā hōʻike a me nā hopena ʻaoʻao o Glidiab
He aha nā loiloi e pili ana iā Glidiab? Hoʻomaopopo maikaʻi aku ka maʻi diabetes. Hoʻohana ʻia ka poʻe nui e ka uku haʻahaʻa o ka lāʻau lapaʻau, a me nā hōʻailona hana kiʻekiʻe.
Eia kekahi, ʻO Glidiab, e like me ka maʻi maʻi, he maikaʻi no ka mea maʻamau ke kumu i nā hopena ʻala ma nā wahi haʻahaʻa. ʻO kekahi ʻano hōʻailona o ka lāʻau lapaʻau i nā kānaka ka mea ʻoi ka hoʻonui i ka pono o ka mālama kai.
He aha nā hopena kūpono e hiki ai ke kumu lāʻau lapaʻau hypoglycemic? Wahi a nā ʻōlelo aʻoaʻo, hiki i ka lāʻau lapaʻau ke kumu:
- Nā kuhihewa o ka ʻōnaehana endocrine. Hōʻike lākou i kahi hypoglycemia. Akā e hoʻomanaʻo ʻia aia ka hoʻopiʻi ʻana i kēia hoʻopiʻi me kahi ʻano kūpono ʻole o ka lāʻau.
- ʻO ka huhū, ke kahakaha, nā hōʻeha o ka hoʻoulu ʻana, ka pu ʻana o nā wāwae, ka ʻeha, ka dizz, ke hoʻonui nui ʻana.
- Hoʻemi ka ʻike maka pono ʻole.
- ʻAhapasia.
- Bradycardia
- Ewa ana ka ea.
- Delirium.
- Thrombocytopenia, anemia, leukopenia.
- Allergic hopena pili.
- ʻOi ka hoʻopili hewa ʻana i ka ʻōnaehana. Hiki i kekahi kanaka ke loaʻa i ke kīhī, ke kaumaha i ka wahi epigastric, nausea, anorexia, jaundice cholestatic, hoʻonui i ka hana o nā transaminases hepatic.
ʻO ka maʻamau, ʻo nā hopena ʻaoʻao e hoʻoholo iā lākou iho ma hope o ka hoʻokuʻu ʻana i ka lāʻau a hele i ke ʻano hōʻailona maʻi kūpono.
ʻO ka analogue maikaʻi loa o Glidiab
He aha nā helu o Glidiab? Ma ke ʻano, hiki ke hoʻohana ʻia nā lawelawe āpau hypoglycemic e pili ana i ka metformin hydrochloride. He ʻano hui maikaʻi nā hui analog. ʻO kēia lāʻau lapaʻau ka mea maikaʻi loa o Glidiab.
ʻO ke kumukūʻai o ka lāʻau lapaʻau e pili ana i ka 180-260 rubles. Loaʻa ka Formmetin i loko o kahi waihona o 500 mg, 850 mg a me ka 1 gram. ʻO ka pālahalaha he 60 papa. ʻO ka mana o nā lāʻau hoʻohui ka metformin hydrochloride, povidone, primellose, magnesium stearate.
Pehea ka hana o ka hana ʻano o ka formin? Hōʻike ka ʻōlelo aʻoaʻo e hoʻopili ana ka metformin hydrochloride i ke kaʻina hana o ka gluconeogenesis ma loko o ka pūpū, a kōkua i ke hōʻemi i ka komo ʻana o ka glucose mai ka pūpū.
Eia hou kekahi, ʻo ka mea hana e hoʻonui ai i ka hoʻohana mua ʻana o ka pehu, a me ke kōkua i ka hoʻonui ʻana i ke ʻano o nā huina i nā hopena o ka insulin. I kēia hihia, ʻaʻole pili ka metformin hydrochloride i ke kaʻina o ka mea huna o ka insulin e nā cell beta, ma muli o ka hopena o ka ulu ʻana o ka hypoglycemia.
Me ke kōkua o Formetin, hiki ke mālama ʻia i ka maʻi diabetes type 2. Hoʻohana pinepine ʻia, hoʻohana ʻia ka lāʻau i ka wā e loaʻa ai ka maʻi diabetes i ka momona a me nā hihia ke kōkua ʻole ka lāʻau lapaʻau e hoʻomaʻamaʻa i nā ʻike glucose koko. Makemake wau makemake e hoʻohana pinepine ʻia ka lāʻau e hui pū me nā lāʻau lapaʻau e pili ana i ka papa o sulfonylurea.
Pehea e lawe ai i ka formin? ʻO ka lāʻau mua ma mua o 1000-1700 mg i kēlā me kēia lā. Eia kekahi, ua mahele ʻia ka dosage i 2 dosis. ʻOi aku ka maikaʻi e lawe i nā paila ma hope o ka ʻaina me ka nui o ka wai.
Inā ʻaʻole hoʻomau ke kō koko koko, a laila hoʻonui ka nui i ka dosage i 2-3 greka i kēlā me kēia lā. ʻO ka nui loa e ʻae ʻia i kēlā me kēia lā o Formetin he 3 mau grika, ʻaʻole keu. Akā e hōʻike ʻia ana nā poʻe maʻi e hoʻopau i kahiʻoi aʻe ma mua o 1 grama i kēlā me kēia lā.
Nā maʻi hoʻohālikelike i ka hoʻohana ʻia ʻana o ka lāʻau lapaʻau:
- Allergy i nā māhele.
- Hana paʻa ʻia nā hana a pau, inā hoʻokaumaha ʻole i ka pilikia.
- ʻO ke kumumānu o ke ahonui myocardial.
- Naʻu?
- Pilikia a lawelawe ʻole paha i ka hanu.
- Ka pōʻino o Cerebrovascular.
- Ka maʻi waʻeha
- ʻŌpū a me ka lactation.
- ʻO kahi kūlana e pono ai ka hoʻohana ʻana i ka insulin. Hiki iā ia ke hōʻeha koʻikoʻi, ʻā ʻia a hōʻoki paha paha.
- Lactic acidosis.
- ʻO ka hoʻokō me ka meaʻai koʻikoʻi, kahi e hoʻolako ai i ka hōʻemi o nā lāhaki i kēlā me kēia lā i 1000 kilocalories.
- Ke noi nei i nā lā 2 o ka hope o nā haʻawina x-ray me ka hoʻomaka ʻana o kahi mea i ʻike ʻia iodine. Ma ke ala, ʻaʻole pono e hoʻopau ka lāʻau lapaʻau i nā lā 2 ma mua o ia ʻano hoʻokolohua X-ray.
I waena o nā hopena hopena o ka lāʻau lapaʻau, aia ka pilikia i ka hana o ke kaomi kūwaho ʻana, ka hōʻeha o ka metabolic, anemia, hypoglycemia a me nā hopena alaka. E hōʻike ka wikiō ma kēia ʻatikala i nā lāʻau no ka maʻi maʻi maʻi.
